Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery (PESTI Trial)

NCT05334485 is registered in ClinicalTrials.gov with Stefan Holubar MD MS FACS, FASCRS as lead sponsor.

NCT NCT05334485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05334485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery (PESTI Trial)
Lead sponsor
Stefan Holubar MD MS FACS, FASCRS
Phase
Phase 2/3
Overall status
Recruiting
Start date
September 3, 2024
Completion date
October 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative ileus